Patterns, trends and sex differences in HIV/AIDS reported mortality in Latin American countries: 1996-2007

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Alonso Gonzalez, Monica ^a   Martin, Luise ^a,b   Munoz, Sergio ^c   Jacobson, Jerry O ^d  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b Carlo Schmid Program   (Germany)

^c UNIVERSIDAD DE LA FRONTERA   (Chile)

^d PAN AMERICAN HEALTH ORGANIZATION   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; DEATH CERTIFICATE; FEMALE; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; MORTALITY; SEX RATIO; SOUTH AND CENTRAL AMERICA;

ADULT; AGE DISTRIBUTION; ANTI-HIV AGENTS; DEATH CERTIFICATES; FEMALE; HEALTH POLICY; HIV INFECTIONS; HUMANS; LATIN AMERICA; MALE; MIDDLE AGED; MORTALITY; SEX DISTRIBUTION;

EID: 84855604401     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-605     Document Type: Article

References (64)

1. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe. Survival after introduction of HAART in people with known duration of HIV-1 infection, Lancet 2000 355 9210 1158 9 10791383
2. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. R Detels, A Munoz, G McFarlane, LA Kingsley, JB Margolick, J Giorgi, et al. JAMA 1998 280 17 1497 503 10.1001/jama.280.17.1497 9809730 (Pubitemid 28507402)
3. Causes of the decline in AIDS deaths, United States, 1995-2002: prevention, treatment or both? DR Holtgrave, Int J STD AIDS 2005 16 12 777 81 10.1258/095646205774988109 16336756 (Pubitemid 43116694)
4. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. A Mocroft, B Ledergerber, C Katlama, O Kirk, P Reiss, MA d'Arminio, et al. Lancet 2003 362 9377 22 9 10.1016/S0140-6736(03)13802-0 12853195 (Pubitemid 36835816)
5. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. FJ Palella Jr, KM Delaney, AC Moorman, MO Loveless, J Fuhrer, GA Satten, et al. N Engl J Med 1998 338 13 853 60 10.1056/NEJM199803263381301 9516219 (Pubitemid 28135961)
6. Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category. S Perez-Hoyos, AJ Del, R Muga, RJ del, OP Garcia de, R Guerrero, et al. AIDS 2003 17 3 353 9 10.1097/00002030-200302140-00009 12556689 (Pubitemid 36223260)
7. VIH y sida en Espãa. Situacián epidemiolágica 2001. Secretaría del Plan Nacional sobre SIDA, Madrid: Ministerio de Sanidad y Consumo 2002
8. Survival after AIDS diagnosis in Italy, 1999-2006: a population-based study. D Serraino, A Zucchetto, B Suligoi, S Bruzzone, L Camoni, S Boros, et al. J Acquir Immune Defic Syndr 2009 52 1 99 105 10.1097/QAI.0b013e3181a4f663 19448558
9. Regional disparities in HIV-related deaths and access to HAART: evidence from a province-wide universal healthcare system. E Druyts, KJ Lepik, A Anema, W Zhang, KA Muldoon, RS Hogg, et al. Cape Town, South Africa 2009
10. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. P Braitstein, MW Brinkhof, F Dabis, M Schechter, A Boulle, P Miotti, et al. Lancet 2006 367 9513 817 24 16530575
11. Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. AJ Herbst, GS Cooke, T Barnighausen, A KanyKany, F Tanser, ML Newell, Bull World Health Organ 2009 87 10 754 62 10.2471/BLT.08.058982 19876542
12. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. A Jahn, S Floyd, AC Crampin, F Mwaungulu, H Mvula, F Munthali, et al. Lancet 2008 371 9624 1603 11 10.1016/S0140-6736(08)60693-5 18468544 (Pubitemid 351626844)
13. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2009. World Health Organization, UNAIDS, UNICEF, Geneva: WHO 2009
14. Mortality and burden of disease attributable to selected major risks. World Health Organization. Global health risks, Geneva: World Health Organization 2009
15. AIDS Epidemic Update 2009. UNAIDS, WHO, Geneva: Joint United Nations Programme on HIV/AIDS 2009
16. Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean. SH Tuboi, M Schechter, CC McGowan, C Cesar, A Krolewiecki, P Cahn, et al. J Acquir Immune Defic Syndr 2009 51 5 615 23 10.1097/QAI.0b013e3181a44f0a 19430306
17. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Sd Lawn, AD Harries, R Wood, Curr Opin HIV AIDS 2010 5 1 18 26 10.1097/COH.0b013e328333850f 20046144
18. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. The ART-LINC Collaboration of the International Databases to Evaluate AIDS (IeDEA), Tropical Medicine & International Health 2008 13 7 870 9 21808007
19. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. D Nash, M Katyal, MW Brinkhof, O Keiser, M May, R Hughes, et al. AIDS 2008 22 17 2291 302 10.1097/QAD.0b013e3283121ca9 18981768
20. Boletín sobre el VIH-SIDA en la Argentina: Ão XII-número 26-noviembre de 2009. [Ão XII-número 26]. 2009. Buenos Aires, Ministerio de Salud, presidencia de la Nacion. Ministerio de Salud de Argentina, Boletín sobre el VIH-SIDA en la Argentina 21216839
21. AIDS mortality trends in Mexico, 1988-1997. Hernández-Girán Carlos, Tovar-Guzmán Víctor, del Río Carlos, Salud pública Méx [serial on the Internet] 2002 44 3 207 12 1149961
22. Evolucián y situacián epidemiolágica de la infeccián por virus de inmunodeficiencia humana y síndrome de inmunodeficiencia adquirida en Chile. M García, A Olea, Rev Chil Infect 2008 25 3 162 70
23. El sida en Mexico en el ão 2000. La respuesta mexicana al sida: Mejores practicas. C Magis-Rodríguez, E Bravo-García, P Rivera, Mexico City: Instituto Nacional de Salud Publica de Mexico 2000
24. Universal access, six years results in the Mexico City HIV/AIDS Program. Soler Claudín Carmen, Salud pública Méx [serial on the Internet] 2009 51 1 26 33 1149961
25. Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico. S Bautista-Arredondo, A Mane, S Bertozzi, AIDS 2006 20 101 9 10.1097/01.aids. 0000198096.08444.53 16327325 (Pubitemid 41818120)
26. Nuevas evidencias en VIH-Perú C Caceres, W Mendoza, K Konda, A Lescano, Lima: Universidad Peruana Cayetano Heredia; Organizacián Panamericana de la Salud 2007
27. Situacián epidemiolágica de VIH/SIDA, Chile 1984-2008. Ministerio de Salud de Chile, Santiao de Chile, Chile: Ministerio de Salud de Chile 2009
28. Impact of highly active antiretroviral therapy (HAART) on the incidence of opportunistic infections, hospitalizations and mortality among children and adolescents living with HIV/AIDS in Belo Horizonte, Minas Gerais State, Brazil. TM Candiani, J Pinto, CA Cardoso, IR Carvalho, AC Dias, M Carneiro, et al. Cad Saude Publica 2007 23 Suppl 3 414 S423 17992347
29. Regional patterns of the temporal evolution of the AIDS epidemic in Brazil following the introduction of antiretroviral therapy. AM Brito, EA Castilho, CL Szwarcwald, Braz J Infect Dis 2005 9 1 9 19 15947842 (Pubitemid 41686161)
30. Boletín Epidemiolágico Municipal de VIH/SIDA. Publicacián del Programa Municipal de Sida y el Sistema Municipal de Epidemiología, Ão 10 2008 Report No.: 10
31. Mortality caused by AIDS in Mexico: an analysis of future trends and projections. MP Rivera Reyes, K Sánchez Sánchez, 2008
32. Health Situation in the Americas: Basic Indicators 2008. 1-6-2008. Washington, D.C, Pan American Health Organization. Pan American Health Organization, Health Situation in the Americas: Basic Indicators. PAHO: Health Information and Analysis 2010
33. Health Situation in The Americas. Basic Indicators 2009. Pan American Health Organization, Washington DC, Pan American Health Organization. Health Situation in the Americas: Basic Indicators. Pan American Health Organization, Health Information and Analysis, Pan American Health Organization, 2009 1-2-2010
34. Health Statistics from the Americas, 2006 Edition. http://www.paho.org/ english/dd/ais/HSA2006-TOC.pdf [cited 2010 Apr 20]
35. RECOMENDACIONES PARA EL TRATAMIENTO ANTIRRETROVIRAL. Direcciánde Sida y ETS del Ministerio de Salud de la Nacián Argentina, Buenos Aires, Argentina; 7 A.D 2007 21808980
36. Efecto de la terapia antirretroviral en la rehospitalizacián por enfermedad oportunista en Costa Rica. Wong-McClure Roy, Leán-Bratti María-Paz, Acta méd.costarric 2006 48 4 179 184 1-2-2011 21781056
37. Precoz tratamiento antirretroviral logra reducir la mortalidad por sida. C Schumacher, Nacián.com/aldea global 4-23-0009 21800621
38. Situacián del VIH/SIDA y respuesta a la epidemia. M Bortman, L Saenz, I Pimenta, C Isern, AE Rodriguez, M Miranda, et al. Washington, DC: Banco Internacional de Reconstruccián y Fomento/Banco Mundial 2006
39. AIDS in Latin America. T Frasca, New York: Palgrave MacMillan 2005
40. Toward Universal Access to HIV Prevention, Care, and Treatment. Pan American Health Organization, 3 by 5 Report for the Americas Washington DC: Pan American Health Organization 6 A.D. Jun 20
41. HIV in older adults. MJ Simone, J Appelbaum, Geriatrics 2008 63 12 6 12 19061274
42. HIV infection in the elderly. N Nguyen, M Holodniy, Clin Interv Aging 2008 3 3 453 72 18982916
43. HIV infection and advanced age emerging epidemiological, clinical, and management issues. R Manfredi, Ageing Res Rev 2004 3 1 31 54 10.1016/j.arr.2003.07.001 15164725 (Pubitemid 38177437)
44. Survival of AIDS patients using two case definitions, Rio de Janeiro, Brazil, 1986-2003. DP Campos, SR Ribeiro, B Grinsztejn, VG Veloso, FI Bastos, MG Morgado, et al. AIDS 2005 19 22 S26 10.1097/01.aids.0000191486.92285.1c 16249649
45. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. D Nash, M Katyal, MW Brinkhof, O Keiser, M May, R Hughes, et al. AIDS 2008 22 17 2291 302 10.1097/QAD.0b013e3283121ca9 18981768
46. Determinants of Treatment Access in a Population-based Cohort of HIV-positive Men and Women Living in Argentina. C Zala, CA Rustad, K Chan, NI Khan, M Beltran, E Warley, et al. J Int AIDS Soc 2008 10 4 78 10.1186/1758-2652-10-4-78 19825142
47. LAC reported HIV cases. 2010 http://new.paho.org/hq/index.php?option=com- content&task=view&id=1610&Itemid=1410 [cited 2010 Jan 6]
48. Status of the HIV/AIDS epidemic and methods to monitor it in the Latin America and Caribbean region. JM Calleja, N Walker, P Cuchi, S Lazzari, PD Ghys, F Zacarias, AIDS 2002 16 Suppl 3 3 12 12698994
49. El SIDA en las mujeres: logros y asignaturas pendientes. P Uribe-Zũiga, C Magis-Rodriguez, E Bravo Garcia, C Gayet Serrano, L Villegas-Icazabalceta, G Hernandez-Tepechin, Perinatol Reprod Hum 2003 17 255 70
50. A life course approach to patterns and trends in modern Latin American sexual behavior. M Bozon, C Gayet, J Barrientos, J Acquir Immune Defic Syndr 2009 51 Suppl 1 4 S12 19384100
51. Social position, gender role, and treatment adherence among Colombian women living with HIV/AIDS: social determinants of health approach. M Arrivillaga, M Ross, B Useche, ML Alzate, D Correa, Rev Panam Salud Publica 2009 26 6 502 10 10.1590/S1020-49892009001200005 20107704
52. Paying the price for late starts and early stops: racial and sex disparities in HIV-related mortality. KY Smith, Clin Infect Dis 2009 49 10 1579 81 10.1086/644773 19845470
53. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. KA Gebo, JA Fleishman, R Conviser, ED Reilly, PT Korthuis, RD Moore, et al. J Acquir Immune Defic Syndr 2005 38 1 96 103 10.1097/00126334-200501010-00017 15608532 (Pubitemid 40094126)
54. HIV/AIDS Surveillance Report, 2007. Centers for Disease Control and Prevention, Atlanta, U.S, Department of Health and Human Services, Centers for Disease Control and Prevention, Department of Health and Human Services CfDCaP, 2010 [19]. 7-3-2010
55. Mortality in the Swiss HIV Cohort Study (SHCS. and the Swiss general population. C Jaggy, OJ von, B Ledergerber, C Schwarz, M Egger, M Rickenbach, et al. Lancet 2003 362 9387 877 8 10.1016/S0140-6736(03)14307-3 13678976 (Pubitemid 37130098)
56. Antiretroviral therapy of late presenters with advanced HIV disease. M Battegay, J Fehr, U Fluckiger, L Elzi, J Antimicrob Chemother 2008 62 1 41 4 10.1093/jac/dkn169 18408235 (Pubitemid 351865872)
57. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress Report 2007. World Health Organization, UNAIDS, UNICEF, Geneva, World Health Organization, World Health Organization, 2007
58. Progress on global access to HIV antiretroviral therapy: a report on "3 by 5" and beyond, March 2006. World Health Organization, Geneva: World Health Organization 2006
59. Impact of HIV infection on mortality and accuracy of AIDS reporting on death certificates. NA Hessol, SP Buchbinder, D Colbert, S Scheer, R Underwood, JL Barnhart, et al. Am J Public Health 1992 82 4 561 4 10.2105/AJPH.82.4.561 1546772
60. Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil. AG Pacheco, SH Tuboi, SB May, LF Moreira, L Ramadas, EP Nunes, et al. J Acquir Immune Defic Syndr 2009 51 5 624 30 10.1097/QAI.0b013e3181a4ecf5 19430304
61. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HB Krentz, G Kliewer, MJ Gill, HIV Med 2005 6 2 99 106 10.1111/j.1468-1293.2005.00271.x 15807715 (Pubitemid 40425973)
62. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. K Bhaskaran, O Hamouda, M Sannes, F Boufassa, AM Johnson, PC Lambert, et al. JAMA 2008 300 1 51 9 10.1001/jama.300.1.51 18594040 (Pubitemid 351920404)
63. Gender, sex, and HIV: how well are we addressing the imbalance? C Hankins, Curr Opin HIV AIDS 2008 3 4 514 20 10.1097/COH.0b013e32830136b4 19373014
64. Is there a gender gap in the HIV response? Evaluating national HIV responses from the United Nations General Assembly Special Session on HIV/AIDS country reports. M Carael, H Marais, J Polsky, A Mendoza, J Acquir Immune Defic Syndr 2009 52 Suppl 2 111 S118 19901623